27.S-
THE USE OF PROBIOTICS IN INTESTINAL PROTECTION
Emma Southcott B. Sc.
(Ilons)
A
thesis submittedfor
the degree of Doctor of PhilosophyDepartment of Physiology, The
University
of Adelaide, Adelaide, SouthAustralia
The Centrefor
Paediatric and Adolescent Gastroenterology'Women's and Children's Hospital, Adelaide, South Australia
By
November 2002
T¡.nr,n oF
CoNTENTSAssrRAcr
DecrnRertoN AcTNowLBDGMENTS AssREvlRrIoNs Attr,ls on THBsts
Hvpotgns¡s
RBSSRR.cHPTRN
CHAPTER 1 INTRODUCTION
TsB GIsTRoINTESTINAT BRnnren Bacterial PoPulalíon
Short chain fattY øcid Productìon Mucus Production
I
nte stin al m u co s al inte gritY Macosal immune sYstem Neuroendocrine sYstem INresrrN¡.1P¡nvnneIrtrY
P ør a c ellul ar P erm e ab ílitY Tr an s cellular P erm eabilitY Common PathwaYs
MENSUREN,IENT OF INTESTINAL PERMEABILITY CarbohYdrøtes
Chromium-Sl-tabetledethylenediamínetetrøa'ceticacid
Animal
studiesMOPBI.S OF COMPROMISED INTESTINAL INTEGRITY Methotrexate animal model of íntestinal damage Inflammøtory B owel Disease
SPorts athletes PRostortcs
Deft'nítíon Probíotíc safetY
Probiotic muctts ødhesion
Probiotícs and gastrointestinsl health
VI VII VIII
x
IX X 1
1
3 4 5 6 6 7 8
I
13 13
l4
14 15 16 18 18 21 27 29 29 30 35 37
Probiotics treøtment
in
intestinaldamøge
40Surr¿vnnv
45CHAPTER 2 INTESTINAL PERMEABILITY DETERMINATION AND PROBIOTIC ADMINISTRATION IN TIIE NORMAL RAT.
49INrRooucttot¡
49Mersoos
50Study 1: Overnìght fasting or feeding
prior
to ø permeabilitytesl
51Study 2: EJfects of a probiotic dìet on intestinal permeability in healthy
rats 5I
Rrsurrs
54Study 1: Overnightfastìng orfeedíng
prior
to a permeabilitytest
57Study 2:
Elþcts
of a probiotic diet on intestinal permeabílity ìn healthyrats
57DrscusstoN
59CHAPTER 3 PROBIOTICS AND METHOTREXATE.INDUCED SMALL
BOWEL DAMAGE IN THE RAT.
62INrRopucuo¡t
62MprHoos
63Resut.rs
10DlscussloN
79CHAPTER 4 SMALL INTESTINAL PERMEABILITY IN PAEDIATRIC
INFLAMMATORY BOWEL
DISEASEPATIENTS
84INrnopucrtoN
84Mnrsoos
85Resulrs
88DtscussloN
95CHAPTER 5 INFLAMMATORY BOWEL DISEASE: EFFECTS OF
SHORT-TERM PROBIOTIC ADMINISTRATION.
99INtRooucrtoN
99METHODS
1OORssut-rs
102DtscussloN
108CHAPTER 6 SMALL INTESTINAL PERMEABILITY AND THE EFFECT
OFPROBIOTICS DURING EXERCISE. II2
INrRoouctIoN ll2
Mersoos
113111
Study
I:
Intestinal permeability, moderate exercíse and endurancetraining
Study 2: Probíotics treatment during endurøncetrainíng
Rnsulrs
Study 7: Intestínal permeabilily, moderate exercise ønd endurance
trainíng
Study 2: Probiotics treatment during endurancetraining
DtscussloN
CHAPTER 7 BUTYRATE ALTERS THE ADHESION
PROPERTIESLACTOBACILLUS
STRAINS TO MUCUS.INtRoouctIoN
MRrpru¡,ls AND MBrHoos
R¡suLrs
DtscusstoN
CHAPTER 8 SUMMARY,
CONCLUSIONS AND FUTUREDIRECTIONS.
Furunn sruDIES
CHAPTERg
REFERENCESAPPENDIX
I
APPENDIX
II
113 118 t22 122 126 132 OF 138 138
t39
t4l
t42
144 151
154 t97
198
Ansrnlcr
While
studies have suggested that gastrointestinal pathogenicity associatedwith
conditions such as inflammatory bowel disease and chemotherapy induced mucositis can be improved by the use of probiotics, the mechanisms of probiotic protection are not clearly understood.Such knowledge is necessary
to
achieve maximum benefitfrom
such formsof
treatment.These investigations wero undertaken
to initially
establisha
non-invasive measureof
intestinal ba:rier function and then
to
examine the protective effectsof
different yoghurtson
conditionswhich
causes lossof barrier
function: chemotherapy induced mucositis;inflammatory bowel disease (IBD) patients; and athletes in training.
Different
yoghurts actedon different
regionsof the
intestinein an
animalmodel of
methotrexate-induced small bowel damage. Sheep
milk
yoghurt decreased the severityof proximal small intestinal
damageand
increased sucraseactivity. Probiotic LAI
(Lactobacillus
johnsonii strainlAl)
yoghurt improved intestinal function by maintainingsmall
intestinal permeabilitywith the
developmentof
methotrexate-induced damage' These yoghurts may enhance mucosal recovery after damage'IBD
patients' intestinal permeability was foundto mirror
their diseaseactivity
and may assistin
monitoring diseaseactivity
and directinterventions.
Intestinal permeabilityin
moderately trained recreational athletes was elevated to a levelof
severity seenin
diseaseaffected intestines. The number
of
athleteswith
elevated intestinar permeability increasedwith
the lengthof training. colonic
microflora metabolism, measuredby
faecal shortchain fatty acids (scFA), was significantly
increasedin IBD
patientsand
athletescompared to healthy controls. Probiotic
LAl
yoghurt significantly decreased faecalscFA in
athletes andIBD patients. scFA
also increasedthe
adhesionof
probiotic bacteria'which may affect their colonisation. Probiotic induced intestinal functional changes may be related to SCFA levels.
The function of the small
intestinecan be
compromisedto different
degrees afterchemotherapy drugs, under physiological stress and
in
disease' Probiotics may improve compromised intestines through enhancing recoveryof the
intestinal mucosa and the barrier function.v
Dncl¡.n¡.rron
This thesis contains no material which has been accepted for the award of any other degree or diploma
in
anyinstitution.
To the best of my knowledge andbeliet
this thesis contains no material that had been previously published or written by another person, expect wheredue reference is made in the text.
I
give consent to this copy of my thesis being available for photocopying and loan'Emma Southcott
Signature Date
AcxNowI,EDGMENTS
I would like to
thankmy
supervisorsDr
RossButler,
ProfessorGeoff
Davidson and ProfessorTony
Ferrantefor their
support,insightful
ideas, and guidanceduring
my postgraduate studies. They have been instrumentalin
the developmentof
this project and provided mewith
many opportunitiesto
expand my research skills and present this work nationally and internationally, andfor
thisI
am indebted tothem. I
wishto
express mygratitude
to Dr
KazunoriMiki for
teaching the laboratory techniques neededto
operateHpLC
system andfor
making laboratorywork enjoyable. My
genuine thanksto Dr
Gordon Howarthfor
encouraging me,proving
direction and assistancein
animal trial design and thesis preparation. Thank you toDr
David Tiveyfor
allowing me towork in his
laboratory and alsoto
Nicole Peltonfor
her helpwith
the animaltrial
and analysing intestinal enzymeactivity. In
addition,I
wouldlike
to thank the staff at the Child Health Research Institute for their assistance and expertise in conducting the animaltrials. I
wishto
express gratitudeto
Professor Seppo Salminenfor the
opportunityto work in
his laboratory in Finland and thanks to Pasi, Leea,Inna, Elina and the rest of the laboratory fora wonderful experience on probiotics research.
My
grateful thanks toDr
Jon Buckley for incorporating permeability test in sports trials, for sharing his sports physiology knowledge and for providing useful feedback.I
would like to acknowledge Nestec Ltd. for sponsoring the probiotic trials usingLA1
and Pure Island for donating the Sheep milk yoghurt.I
have enjoyed working at the Centre for Paediatric and Adolescent Gashoenterology and feel fortunateto
have such a fantastic groupof friends. I
thankall
the membersof
the department both past and present for their encouragement, humour and entertaining times' Special thanksto Dr
Cuong Tran, Pat'Westin, Trish Cmielewski andErin
Symonds for theirkind
assistancewith writing
letters and scholarships; for solving laboratory problem;for proof reading this thesis and for all those talks over coffees.
I would like to thank my family and friends for their invaluable support
andencouragement and specially my parents and Michael for their patience in solving so many computer problems. Finally,
I
would like to thank Dr Brent Henderson for conducting the statistical analysis, for proof reading, for providing excellentadvice.
Without your help, finishing this thesis would have been a lot harder'vl1
AnnnnvrarroNS CD
-
Crohn's diseasetlcr
EDTA - slchromium ethylene diamine tetra acetic acid CRP-
C - reactive proteinESR
-
Erythrocyte sedimentation rate GALT-
Gastrointestinal lymphoid tissue HB-
Harvey-BradshawHR
-
Heart rateHRt - Heart rate threshold HRP
-
Horse radish peroxidase IBD-
Inflammatory bowel diseaseIgA
-
ImmunoglobulinA IL
- InterleukinL
- LactuloseLAB -
Lactic acid bacteriaLGG
-
Lactobacillus rhamnosrzs shain GGLAl -
Lactobacillus johnsonii strainLAl
LPS - Lipopolysaccharide
L
Shirota-
Lactobacillus paracøsei subspecies paracasei strain ShirotaM
- MannitolMTX
- MethotrexateNSAIDs
-Non
steroidal anti-inflammatory drugs PCDAI-
Paediatric Crohn's disease activity index PEG-
Polyethylene glycolPP
-
Peyer's patches Rh - Rhamnose R[-
Refractive indexSCFA
-
Short chain fattY acids TNF-
Tumor necrosis factorUC
-
Ulcerative colitisYC-l80 -
mix of Lactobacillus bulgaricus and Streptococcus thermophilus ZO-Zonula
occludinsArvrs on TnnsIs
This thesis seeks to better understand small intestinal permeability and its role
in
barrier function testingin
chemotherapy induced mucositis,IBD
patients and athletes.It
further aimsto
elucidate the interaction of probiotic organismsin
bothhealtþ
and compromisedintestines. It is
hopedthis work will
increase the understandingof
the physiologicalfunction of
intestinal permeabilityin
relationto
theluminal milieu in
orderto
design therapeutic approaches to diseases and conditions with altered permeability.Hvporunsns
The hypotheses of this thesis are that:
1.
Measurementsof
small intestinal permeability can detect abnormalitiesin
barrier function induced by chemical damage, stress, and disease'Z.
probioticswill
improve small intestinal permeabilityin
animal models of intestinal damage and in patients with intestinal disease'J probiotics
will
favourablymodiff
the metabolic activity of the intestinal flora'1X
Rpsn¡.ncnPLAN
The first study involved developing a methodology and protocol for intestinal permeability testing
in
a methotrexate-induced damage rat model in order to investigate the integrityof
the barrier
function.
Chapter Two investigated the effectof
fasting versus feeding state in rats on performanceof
the permeabilitytest.
The influenceof
probioticson
intestinal barrier function was evaluated. Chapter Three examined the small bowel damage inducedby
methotrexatein
rats and the effectof probiotic
interventionof
either Lactobacillus johnsonii strainLAl
or Lactobacillus bulgaricøs (YC-180) on intestinal function'The
secondstudy
determinedthe
usefulnessof small
intestinal permeabilityin
theassessment
of
inflammatorybowel disease.
chapterFour
aimedto
assess intestinal permeability as a non-invasive markerof
disease activity and disease extentin
paediatric inflammatory bowel disease patients. Intestinal permeability was evaluated as a meansof monitoring the
responseto therapy and predicting
diseaserelapse. chapter
Five investigated changesin
intestinal function after a probiotic Lactobacillusjohnsonll
strainLAlsupplementeddietinlBDpatientsandhealthysubjects.
The
third
study (chaptersix)
investigatedthe
effectof training
and probioticson
the intestinal barrier functionof
athletes. Runners had their exercise performance, intestinal permeability and faecalscFA
tested priorto
and after a trainingprogram'
The influenceof
aprobiotic
yoghurt(LAl)
and placebo yoghurton
exercise performance and barrier function over a four week exercise program was tested'The fourth study (chapter
seven) observedthe
adhesionto
intestinal mucusby
twoprobiotic
strains; Lactobacillusjohnsonil
strainLAl
and Lactobacillus bulgaricus(YC-
1g0). The adhesion of these strains was compared to two of the most researched probiotic strains:LGG
andL Shirota. The
adhesion was measuredwith
increasinglevels of tributyrin,
the triglycerideof
butyrate,to
determine the effectof
butyrate on the mucusadhesion of these strains.